Floatz logo

Peripheral Blood Mononuclear Cell

Lymphocytic Lymphoma

University Hospital, Clermont-FerrandCell therapyPhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Lymphocytic Lymphoma cohort.

Asset / SponsorPhaseRating
Fludarabine
University Hospital, Clermont-Ferrand
Phase 2CCC

Same molecule, other indications

Peripheral Blood Mononuclear Cell is also rated in:

ulcer of lower limbsDormant
BB
Indicative ·
64 / 100
View asset →
Critical Limb IschemiaDormant
BB
Indicative ·
64 / 100
View asset →
atherosclerosisDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →